National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford, UK; Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK.
J Clin Epidemiol. 2021 Feb;130:32-41. doi: 10.1016/j.jclinepi.2020.09.020. Epub 2020 Sep 28.
To investigate variation in the presence of secondary diagnosis codes in Charlson and Elixhauser comorbidity scores and assess whether including a 1-year lookback period improved prognostic adjustment by these scores individually, and combined, for 30-day mortality.
We analyzed inpatient admissions from January 1, 2007 to May 18, 2018 in Oxfordshire, UK. Comorbidity scores were calculated using secondary diagnostic codes in the diagnostic-dominant episode, and primary and secondary codes from the year before. Associations between scores and 30-day mortality were investigated using Cox models with natural cubic splines for nonlinearity, assessing fit using Akaike Information Criteria.
The 1-year lookback improved model fit for Charlson and Elixhauser scores vs. using diagnostic-dominant methods. Including both, and allowing nonlinearity, improved model fit further. The diagnosis-dominant Charlson score and Elixhauser score using a 1-year lookback, and their interaction, provided the best comorbidity adjustment (reduction in AIC: 761 from best single score model).
The Charlson and Elixhauser score calculated using primary and secondary diagnostic codes from 1-year lookback with secondary diagnostic codes from the current episode improved individual predictive ability. Ideally, comorbidities should be adjusted for using both the Charlson (diagnostic-dominant) and Elixhauser (1-year lookback) scores, incorporating nonlinearity and interactions for optimal confounding control.
研究 Charlson 和 Elixhauser 合并症评分中二级诊断代码的存在情况的变化,并评估在单独使用和联合使用这些评分时,是否包括 1 年回溯期是否可以改善对 30 天死亡率的预后调整。
我们分析了 2007 年 1 月 1 日至 2018 年 5 月 18 日在英国牛津郡的住院患者。使用诊断主导时期的二级诊断代码和前一年的主要和次要代码计算合并症评分。使用 Cox 模型和自然三次样条评估非线性,使用赤池信息量准则评估拟合度,研究评分与 30 天死亡率之间的关联。
1 年回溯期改善了 Charlson 和 Elixhauser 评分与使用诊断主导方法相比的模型拟合度。同时包含两者,并允许非线性,进一步提高了模型拟合度。使用 1 年回溯期的诊断主导 Charlson 评分和 Elixhauser 评分及其相互作用提供了最佳的合并症调整(最佳单评分模型的 AIC 减少:761)。
使用 1 年回溯期的主要和次要诊断代码以及当前时期的次要诊断代码计算的 Charlson 和 Elixhauser 评分改善了个体预测能力。理想情况下,应同时使用 Charlson(诊断主导)和 Elixhauser(1 年回溯)评分来调整合并症,同时考虑非线性和相互作用,以进行最佳的混杂控制。